Select therapeutic use:
Indications for Flunisolide Spray:
Seasonal or perennial rhinitis.
≥15yrs: Initially 2 sprays in each nostril twice daily; max 8 sprays/nostril per day.
<6yrs: not recommended. 6–14yrs: Initially 1 spray in each nostril 3 times daily or 2 sprays twice daily; max 4 sprays/nostril per day.
Untreated nasal infections.
Maintain regular regimen. Respiratory tract tuberculosis. Infections (eg, ocular herpes simplex). If exposed to measles or chickenpox, consider anti-infective prophylactic therapy. Reduce dose as condition improves. May use nasal decongestants if needed. Discontinue if no effect after 3 wks. If adrenal insufficiency exists following systemic corticosteroid therapy, replacement with topical corticosteroids may exacerbate symptoms of adrenal insufficiency (eg, depression). Monitor for growth suppression in children. Monitor for hypercorticism and HPA axis suppression (if occur discontinue gradually), and candida infection or other nasal mucosal changes. Avoid eyes. Pregnancy (Cat.C). Nursing mothers.
Nasal discomfort, congestion, sneezing, epistaxis, lacrimation, sore throat, nausea, headache, loss of taste and smell, septal perforation, hypercorticism, fungal overgrowth, impaired wound healing, glaucoma, reduced growth velocity in children.
Formerly known under the brand names Nasalide, Nasarel.